Vireo Growth Completes Acquisition of Convertible Notes from Schwazze
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 14 2025
0mins
Should l Buy ?
Transaction Overview: Vireo Growth (VREOF) has acquired senior secured convertible notes from Medicine Man Technologies (SHWZ) for approximately $62 million, significantly below the $91 million par value, and issued over 114 million subordinate voting shares in the process.
Restructuring Support Agreement: Vireo has entered into a Restructuring Support Agreement with Schwazze to restructure its operations, which includes selling major assets to a new entity majority-owned by Vireo and winding down Schwazze's remaining operations, subject to regulatory approval.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
